Clinical Trial Update: V-Chordal Adjustable System for Chordal Replacement in Mitral Valve Insufficiency Due to Leaflet Prolapse [Phase 2]

View source ↗

Summary

Phase 2 trial of Edwards Lifesciences' V-Chordal Adjustable System for chordal replacement in mitral valve insufficiency caused by mitral leaflet prolapse has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Prolapse

Snippet

Sponsor: Edwards Lifesciences | Conditions: Mitral Leaflet Prolapse | Phase 2 | Status: TERMINATED